The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 #
Open accessAbstract
Cholangiocarcinomas (CCAs) are aggressive cancers, with high mortality and poor survival rates. Only radical surgery offers patients some hope of cure; however, most patients are not surgical candidates because of late diagnosis secondary to relatively poor accuracy of diagnostic means. MicroRNAs (miRs) are involved in every cancer examined, but they have not been evaluated in primary CCA. In this study, miR arrays were performed on five primary CCAs and five normal bile duct specimens (NBDs). Several miRs were dysregulated and miR-21 was overexpressed in CCAs. miR-21 differential expression in these 10 specimens was verified by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). To validate these findings, qRT-PCR for miR-21 was then performed on 18 additional primary CCAs and 12 normal liver specimens. MiR-21 was 95% sensitive and 100% specific in distinguishing between CCA and normal tissues, with an area under the receiver operating characteristic curve of 0.995. Inhibitors of miR-21 increased protein levels of programmed cell death 4 (PDCD4) and tissue inhibitor of metalloproteinases 3 (TIMP3). Notably, messenger RNA levels of TIMP3 were significantly lower in CCAs than in normals. Conclusions: MiR-21 is overexpressed in human CCAs. Furthermore, miR-21 may be oncogenic, at least in part, by inhibiting PDCD4 and TIMP3. Finally, these data suggest that TIMP3 is a candidate tumor suppressor gene in the biliary tree. (Hepatology 2009.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
miRNAs, Cancer, and Stem Cell Division
Croce, C. M., & Calin, G. A. (2005) · Cell · doi:10.1016/j.cell.2005.06.036 · Cited by 1,329
Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707224200 · Cited by 1,141
The Epidemiology of Cholangiocarcinoma
Shaib, Y., & El-Serag, H. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828889 · Cited by 1,132
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051
Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
Patel, T. (2001) · Hepatology · doi:10.1053/jhep.2001.25087 · Cited by 1,010
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
de Groen, P. C., Gores, G. J., LaRusso, N. F., Gunderson, L. L., & Nagorney, D. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910283411807 · Cited by 955
Self-citationMicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00479-08 · Cited by 888
mir-29 regulates Mcl-1 protein expression and apoptosis
Mott, J. L., Kobayashi, S., Bronk, S. F., & Gores, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210436 · Cited by 834
Self-citationE2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
Petrocca, F., Visone, R., Onelli, M. R., Shah, M. H., Nicoloso, M. S., de Martino, I., Iliopoulos, D., Pilozzi, E., Liu, C.-G., Negrini, M., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.013 · Cited by 831
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin, Zhu, Hailong, H., Wu, Fangting, Daotai, Nie, Shijie, Sheng, Yin-Yuan, et al. (2008) · Cell Research · Cited by 831
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
Lu, Z., Liu, M., Stribinskis, V, Klinge, C. M., Ramos, K. S., Colburn, N. H., & Li, Y. (2008) · Oncogene · doi:10.1038/onc.2008.72 · Cited by 711
Ladeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L., Rebouissou, S., & Zucman-Rossi, J. (2008) · Hepatology · doi:10.1002/hep.22256 · Cited by 684
Slaby, O., Svoboda, M., Fabian, P., Smerdova, T., Knoflickova, D., Bednarikova, M., Nenutil, R., & Vyzula, R. (2007) · Oncology · doi:10.1159/000113489 · Cited by 682
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Blechacz, B., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22310 · Cited by 681
Self-citationComplex roles of tissue inhibitors of metalloproteinases in cancer
Jiang, Y., Goldberg, I. D., & Shi, Y. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205291 · Cited by 507
MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma†‡
Varnholt, H., Drebber, U., Schulze, F., Wedemeyer, I., Schirmacher, P., Dienes, H., & Odenthal, M. (2008) · Hepatology · doi:10.1002/hep.22158 · Cited by 431
MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
Dillhoff, M., Liu, J., Frankel, W., Croce, C., & Bloomston, M. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0584-x · Cited by 408
Cholangiocarcinoma: Modern advances in understanding a deadly old disease
Malhi, H., & Gores, G. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.001 · Cited by 269
Self-citationImplications of micro-RNA profiling for cancer diagnosis
Cummins, J. M., & Velculescu, V. E. (2006) · Oncogene · doi:10.1038/sj.onc.1209914 · Cited by 266
Connolly, E., Melegari, M., Landgraf, P., Tchaikovskaya, T., Tennant, B. C., Slagle, B. L., Rogler, L. E., Zavolan, M., Tuschl, T., & Rogler, C. E. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080096 · Cited by 248
Zhang, H., Ozaki, I., Mizuta, T., Hamajima, H., Yasutake, T., Eguchi, Y., Ideguchi, H., Yamamoto, K., & Matsuhashi, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209634 · Cited by 247
Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes
Meng, F., Wehbe-Janek, H., Henson, R., Smith, H., & Patel, T. (2008) · Oncogene · doi:10.1038/sj.onc.1210648 · Cited by 244
“Natural History” of Unresected Cholangiocarcinoma: Patient Outcome After Noncurative Intervention
Farley, D. R., Weaver, A. L., & Nagorney, D. M. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.5.425 · Cited by 232
Surgical Management of Cholangiocarcinoma
Jarnagin, W., & Shoup, M. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828895 · Cited by 226
Patel, T. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0389 · Cited by 224
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death
Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T., & Honjo, T. (1995) · Gene · doi:10.1016/0378-1119(95)00607-9 · Cited by 223
Aberrant CpG Island Methylation of Multiple Genes in Intrahepatic Cholangiocarcinoma
Lee, S., Kim, W. H., Jung, H., Yang, M. H., & Kang, G. H. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64262-9 · Cited by 143
Establishment of a New Extrahepatic Bile Duct Carcinoma Cell Line, TFK-1.
Saijyo, S., Kudo, T., Suzuki, M., Katayose, Y., Shinoda, M., Taisei, M. U. T. O., Fukuhara, K., Suzuki, T., & Matsuno, S. (1995) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.177.61 · Cited by 139
Brand, K., Baker, A. H., Pérez‐Canto, A., Possling, A., Sacharjat, M., Geheeb, M., & Arnold, W. (2000) · PubMed · Cited by 103
Programmed cell death protein 4 (pdcd4): A novel target for antineoplastic therapy?
Lankat–Buttgereit, B., & Göke, R. (2003) · Biology of the Cell · doi:10.1016/j.biolcel.2003.09.003 · Cited by 95
Mahller, Y. Y., Vaikunth, S. S., Ripberger, M. C., Baird, W. H., Saeki, Y., Cancelas, J. A., Crombleholme, T. M., & Cripe, T. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2734 · Cited by 88
Frequent Epigenetic Inactivation of Spleen Tyrosine Kinase Gene in Human Hepatocellular Carcinoma
Yuan, Y., Wang, J., Li, J., Wang, L., Li, M., Yang, Z., Zhang, C., & Dai, J. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0921 · Cited by 77
Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers
Karikari, C. A., Mullendore, M. E., Eshleman, J. R., Argani, P., Leoni, L. M., Chattopadhyay, S., Hidalgo, M. M., & Maitra, A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0103 · Cited by 35
Self-citationZhang, H., Wang, Y.-S., Han, G., & Shi, Y. (2007) · PubMed · Cited by 23
(2008) · PubMed
Cited by
Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
Zen, K., & Zhang, C. (2012) · Medicinal Research Reviews · doi:10.1002/med.20215 · Cited by 502
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Wang, X., He, Y., Mackowiak, B., & Gao, B. (2021) · Gut · doi:10.1136/gutjnl-2020-322526 · Cited by 495
Negative regulation of lncRNA GAS5 by miR-21
Zhang, Z., Zhu, Z., Watabe, K., Zhang, X., Bai, C., Xu, M., Wu, F., & Mo, Y.-Y. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.110 · Cited by 416
Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
Tomimaru, Y., Eguchi, H., Nagano, H., Wada, H., Kobayashi, S., Marubashi, S., Tanemura, M., Tomokuni, A., Takemasa, I., Umeshita, K., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.026 · Cited by 361
TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3
Wang, B., Hsu, S. H., Majumder, S., Kutay, H., Huang, W., Jacob, S. T., & Ghoshal, K. (2010) · Oncogene · doi:10.1038/onc.2009.468 · Cited by 348
Metadata
- Authors
- Selaru, F. M., Olaru, A. V., Kan, T., David, S., Cheng, Y., Mori, Y., Yang, J., Paun, B., Jin, Z., Agarwal, R., Hamilton, J. P., Abraham, J., Georgiades, C., Alvarez, H., Vivekanandan, P., Yu, W., Maitra, A., Torbenson, M., Thuluvath, P. J., Gores, G. J., LaRusso, N. F., Hruban, R., & Meltzer, S. J.
- Venue
- Hepatology
- Published
- 2009-05
- Volume
- 49
- Issue
- 5
- Pages
- 1595-1601
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2040776936
- Cited by
- 286
- References
- 38
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.